These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 14001457)

  • 1. [S-Sulfanilamido- and 3-sulfanilamido-1,2,4-thiadiazole].
    WOERFFEL U; BEHNISCH R
    Arch Pharm Ber Dtsch Pharm Ges; 1962 Nov; 295/67():811-6. PubMed ID: 14001457
    [No Abstract]   [Full Text] [Related]  

  • 2. [Curative action of 2-isopropyl-5-sulfanilamido-1, 3, 4-thiadiazole on human diabetes mellitus].
    LOUBATIERES A
    C R Hebd Seances Acad Sci; 1955 Nov; 241(20):1422-3. PubMed ID: 13277230
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of the carbonic anhydrase inhibitor 2-acetylamino-1,3,4-thiadiazole-5-sulfonamide (acetazolamide) on citric acid excretion in the urine].
    OTTO H
    Klin Wochenschr; 1958 Jul; 36(13):633-6. PubMed ID: 13564739
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of pancreatic secretion by the carbonic anhydrase inhibitor, 2-acetylamino-1,3,4, thiadiazole-5-sulfonamide (compound No. 6063).
    BIRNBAUM D; HOLLANDER F
    Proc Soc Exp Biol Med; 1952 Oct; 81(1):23-4. PubMed ID: 13047303
    [No Abstract]   [Full Text] [Related]  

  • 5. Biologically active nuclear-substituted sulfonamides. I. Chemical and physical properties of some nuclear-substituted sulfanilamido-2-thiazoles and their syntheses.
    QUAN SF; DANIELS TC; KUMLER WD
    J Am Pharm Assoc Am Pharm Assoc; 1954 Jun; 43(6 1):321-6. PubMed ID: 13174427
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on 3,4-dimethyl-5-sulfanilamido-isoxazole (Nu-445) in humans.
    SARNOFF SJ
    Proc Soc Exp Biol Med; 1948 May; 68(1):23-6. PubMed ID: 18863664
    [No Abstract]   [Full Text] [Related]  

  • 7. Toxicologic and metabolic studies on 2, 4-dimethoxy-6-sulfanilamido-1, 3-diazine (madribon).
    RANDALL LO; BAGDON RE; ENGELBERG R
    Toxicol Appl Pharmacol; 1959 Jan; 1(1):28-37. PubMed ID: 13625313
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapeutic activity of 6-sulfanilamido-2,4-dimethylpyrimidine (elkosin).
    EISMAN PC; GEFTIC SG; LIGENZOWSKI F; MAYER RL
    Proc Soc Exp Biol Med; 1952 Jul; 80(3):493-5. PubMed ID: 14949095
    [No Abstract]   [Full Text] [Related]  

  • 9. CHEMICAL PHARMACOLOGY OF 2-SULFANILAMIDO-3-METHOXYPYRAZINE.
    WIEGAND RG; CHUN AH; SCHERFLING E; LOPEZ F; HERTING RL
    Antimicrob Agents Chemother (Bethesda); 1964; 10():549-53. PubMed ID: 14287991
    [No Abstract]   [Full Text] [Related]  

  • 10. [ON THE PHARMACOKINETICS OF A LONG-ACTING SULFONAMIDE (4-SULFANILAMIDO-5,6-DIMETHOXYPYRIMIDINE) IN NORMAL PERSONS].
    PORTWICH F; BUETTNER H
    Klin Wochenschr; 1964 Aug; 42():740-4. PubMed ID: 14296354
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapeutic studies with 2, 4-dimethoxy-6-sulfanilamido-1, 3-diazine (madribon).
    SCHNITZER RJ; DELORENZO WF; GRUNBERG E; RUSSOMANNO R
    Proc Soc Exp Biol Med; 1958 Nov; 99(2):421-4. PubMed ID: 13601890
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of the kinetics, elimination & transit of gantrisin (3,4-dimethyl-5-sulfanilamido-isoazole). I].
    LAPP C
    Clin Chim Acta; 1957 Oct; 2(5):429-41. PubMed ID: 13489880
    [No Abstract]   [Full Text] [Related]  

  • 13. The efficacy of 4-sulfanilamido-6-methoxypyrimidine in standardized infections in mice.
    REDIN GS; McCOY ME
    Chemotherapia (Basel); 1962; 4():386-97. PubMed ID: 14490938
    [No Abstract]   [Full Text] [Related]  

  • 14. The bacteriologicoclinical evaluation of 2,4-dimethoxy-6-sulfanilamido-1, 3-diazine (Madribon) in various urological disorders associated with urinary tract infection.
    SIERP M; DRAPER JW
    Ann N Y Acad Sci; 1959 Sep; 82():92-104. PubMed ID: 14446539
    [No Abstract]   [Full Text] [Related]  

  • 15. SERUM CONCENTRATION AND ANTIBACTERIAL ACTIVITY OF 4-SULFANILAMIDO-5,6DIMETHOXYPYRIMIDINE.
    MADSEN ST
    Am J Med Sci; 1964 Feb; 247():217-22. PubMed ID: 14124711
    [No Abstract]   [Full Text] [Related]  

  • 16. The treatment of pneumonia and other infections with a soluble sulfonamide, gantrosan (NU-445; 3,4-dimethyl-5-sulfanilamido-isoxazole).
    BRICKHOUSE RL; LEPPER MH
    Am J Med Sci; 1949 Aug; 218(2):133-7. PubMed ID: 18135998
    [No Abstract]   [Full Text] [Related]  

  • 17. PURINE METABOLISM IN THE CHICK EMBRYO: INFLUENCE OF 2-SUBSTITUTED THIADIAZOLES.
    KRAKOFF IH
    Biochem Pharmacol; 1964 Mar; 13():449-59. PubMed ID: 14157607
    [No Abstract]   [Full Text] [Related]  

  • 18. On the chemotherapeutic properties of some thiazolylphenylsulphones.
    DAHLBOM R; EKSTRAND T; FRISK AR
    Acta Pharmacol Toxicol (Copenh); 1946; 2(4):371-8. PubMed ID: 20295482
    [No Abstract]   [Full Text] [Related]  

  • 19. Carbonic anhydrase inhibition. V. N5-substituted 2-acetylamino-1,3,4-thiadiazole-5-sulfonamides: metabolic conversion and use as control substances.
    MAREN TH
    J Pharmacol Exp Ther; 1956 Aug; 117(4):385-401. PubMed ID: 13358050
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of gastric secretion of acid in dogs by carbonic anhydrase inhibitor, 2-acetylamino-1, 3, 4-thiadiazole-5-sulfonamide.
    JANOWITZ HD; COLCHER H; HOLLANDER F
    Am J Physiol; 1952 Nov; 171(2):325-30. PubMed ID: 13007797
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.